about
The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersActivity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesPrioritisation of structural variant calls in cancer genomes.Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.Combating subclonal evolution of resistant cancer phenotypes.Alternative empirical Bayes models for adjusting for batch effects in genomic studies.Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes
P50
Q26747403-98C09E85-33E1-48F6-B57A-1AEF6482DAD3Q33608593-7B2DF942-9483-49C1-99DC-0B7586BC9CCEQ36341565-8CF78080-1C5C-4A5E-B127-F3579F79F18EQ38787641-09978D2A-F6AB-454B-824F-A0278A0696CEQ44346336-F338CAE3-82D8-4DAC-986A-3464A010EB8DQ45374759-1FAAE416-255B-44C5-9833-A06EE946A3DCQ55628272-9065C93F-4447-41D2-B9FC-6FD8F14E0525Q93128639-AFC98FC2-8D8E-43D3-8FA8-73F17AC97041
P50
description
researcher ORCID ID = 0000-0002-7451-4288
@en
wetenschapper
@nl
name
David F Jenkins
@ast
David F Jenkins
@en
David F Jenkins
@nl
type
label
David F Jenkins
@ast
David F Jenkins
@en
David F Jenkins
@nl
prefLabel
David F Jenkins
@ast
David F Jenkins
@en
David F Jenkins
@nl
P106
P21
P31
P496
0000-0002-7451-4288